LENSAR reported Q3 2026 revenue of $14.1M, slightly down 1% year-over-year due to lower system sales but offset by a 17% rise in recurring revenue to $12.6M and a 12% increase in procedure volume. The installed base of its ALLY robotic cataract laser systems expanded 22% to about 225 units, supporting future recurring revenue growth. Despite a net loss of $4.7M, adjusted EBITDA improved to $1.7M, reflecting operational progress. The company remains focused on innovation and expanding ALLY system adoption to drive long-term growth.
LENSAR's Q3 2026 financial results provide context for readers. For those following the health sector, 85 of 150 US health stocks on Pluang rose while 56 fell, with FLNA up 7.80%, CGC up 4.37%, and ABCL up 3.68%. This data is as of Nov 10, 2026 18:42 WIB.
The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...
Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...
PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...
Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
